New drug accessibility and budgetary impact in South Korea: policy challenges and implications
While South Korea has effectively controlled pharmaceutical expenditures, allocations for new drugs remain low compared to other major countries.
Authors
- Se-Eun Hwang
- Kyung Min Lim (ORCID: https://orcid.org/0000-0001-5456-255X)
- Ji-Won Jung
- Jong Hyuk Lee (ORCID: https://orcid.org/0009-0001-5903-1800)
- Youngsoo Jang (ORCID: https://orcid.org/0000-0002-8372-5343)
Institutions
- Chung-Ang University (KR)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1080/14737167.2025.2487468
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13